TP53 and neoplasm: Among p53 mutants, missense mutations not only cause the mutated p53 protein to lose its wild-type (LOF) function and gain dominant-negative activity but also increase the function of the mutated p53, leading to the tumor’s more aggressive behavior and drug resistance (Zhang et al., 2022).